Prometic Life Sciences Inc. is a listed company. Filings by its managers are published through SEDI. Nothing new has been filed by managers of Prometic Life Sciences Inc. in twelve months, the latest record being from 5 August 2019.
The full history, which starts in 2015, counts 63 purchases against 84 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 330 declarations
Prometic Life Sciences Inc. is a Canadian biopharmaceutical company focused on developing innovative therapies for rare diseases. It specializes in the research and commercialization of biological products.